Related Experiment Videos

Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen

S S Lau¹, H S Yoon, S K Patel

¹Center for Molecular and Cellular Toxicology, Division of Pharmacology and Toxicology, College of Pharmacy, University of Texas at Austin, 78712-1074, USA.

Advances in Experimental Medicine and Biology

|January 5, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A tetra-nuclear nickel(II) complex, [Ni4(L)4](ClO4)4·C2H3N·2H2O, with an asymmetric Ni4O4 open-cubane-like core.

Acta crystallographica. Section E, Crystallographic communications·2022

Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors.

Breast cancer research and treatment·2021

Medical Care Disruptions During the First Six-Months of the COVID19 Pandemic: The Experience of Older Breast Cancer Survivors.

Research square·2021

The quality of reporting randomized controlled trials in the dermatology literature in an era where the CONSORT statement is a standard.

The British journal of dermatology·2018

Claudin-1 expression decreases with increasing pathological grade in actinic keratosis and may be a marker of high-risk actinic keratosis.

Clinical and experimental dermatology·2018

CD34 stromal expression is inversely proportional to smooth muscle actin expression and extent of morphea.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018

See all related articles